Reevaluating response and failure of medical treatment of endometriosis: a systematic review
This systematic review of medical therapies for endometriosis found that many women experience limited or intermittent pain relief, with significant proportions reporting remaining or recurrent pain and discontinuation due to adverse events or lack of efficacy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This systematic review searched MEDLINE and Embase (through October 13, 2016) for clinical trials and other eligible studies reporting response to a range of medical therapies for endometriosis, extracting patient-level outcomes related to endometriosis-associated pain severity and recurrence where available. It identified 58 eligible studies, most of which used surgical diagnosis and varied in treatment timing (with or without prior surgery), pain measurement tools, and reporting completeness; the authors note that pain response data were reported in only 29 of 58 articles and that some studies reported relevant outcomes only graphically. Across the studies that reported response, the median proportion with lack of response during treatment was highest for GnRH antagonists (~19%) and lower for danazol, GnRH agonists, and progestins (~11–14%), while limited placebo-controlled evidence showed substantial lack of response to placebo (~63%). This paper is centrally about endometriosis—reevaluating response and failure of medical treatments for endometriosis-associated pain via a systematic review of eligible studies.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
36,377 characters
· extracted from
pmc-nxml
· 4 sections
· click to expand
Results
Materials
Conclusion
Discussion
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (100)
- Add-back therapy in the treatment of endometriosis-associated pain via openalex
- Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial via openalex
- Advances in the management of endometriosis: an update for clinicians via openalex
- A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial via openalex
- Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study via openalex
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results via openalex
- Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis via openalex
- Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest Treatment Improves Quality of Life in Women with Endometriosis via openalex
- Effects of laparoscopic ovarian endometriosis cystectomy combined with postoperative GnRH-a therapy on ovarian reserve, pregnancy, and outcome recurrence via openalex
- Effects of Letrozole Compared with Danazol on Patients with Confirmed Endometriosis: A Randomized Clinical Trial via openalex
- Efficacy and safety of nafarelin in the treatment of endometriosis via openalex
- Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study via openalex
- Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex
- Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study via openalex
- Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density via openalex
- Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum via openalex
- Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis via openalex
- Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist via openalex
- How can we measure endometriosis-associated pelvic pain? via openalex
- Introduction: A focus on the medical management of endometriosis via openalex
- Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment via openalex
- Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex
- Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group via openalex
- Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
- Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
- Low-dose add-back therapy during postoperative GnRH agonist treatment via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Medical treatment for rectovaginal endometriosis: what is the evidence? via openalex
- Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET) via openalex
- Nafarelin versus danazol in the treatment of endometriosis via openalex
- Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group via openalex
- Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
- Pain of endometriosis: effects of nafarelin and danazol therapy via openalex
- Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting via openalex
- Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence via openalex
- Progestins for symptomatic endometriosis: a critical analysis of the evidence via openalex
- Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex
- Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Regression of endometriosis following shorter treatment with, or lower dose of danazol. Comparison of pre- and post-treatment laparoscopic findings in the Scandinavian multi-center study via openalex
- Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
- Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- Systematic review of endometriosis pain assessment: how to choose a scale? via openalex
- The efficacy of drugs in the management of endometriosis via openalex
- The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist: Results from a Phase 2, Randomized Controlled Study via openalex
- Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study via openalex
- Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate via openalex
- Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience via openalex
- Updating the clinical experience in endometriosis--the European perspective via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
- Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms via openalex
- World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research via openalex
- Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group via openalex
- W6777152678 via openalex
- W2045089102 via openalex
- W2045458073 via openalex
- W2028587418 via openalex
- W2059444229 via openalex
- W2026056052 via openalex
- W1987239968 via openalex
- W1975627767 via openalex
- W2101417341 via openalex
- W1966091296 via openalex
- W2123876576 via openalex
- W2126339803 via openalex
- W2126729416 via openalex
- W1963640566 via openalex
- W2140726028 via openalex
- W1641053560 via openalex
- W2149682360 via openalex
- W2152955646 via openalex
- W1539284629 via openalex
- W2163315477 via openalex
- W2170519509 via openalex
- W1176421716 via openalex
- W2417044776 via openalex
- W2487791545 via openalex
- W170259557 via openalex
- W3022929224 via openalex
- W3194956376 via openalex
- W4254262221 via openalex
- W4285719527 via openalex
- W6627496481 via openalex
- W6632811936 via openalex
- W6665922062 via openalex
- W6717426660 via openalex
- W2029662381 via openalex
Cited by (50)
- Navigating stigma before and after an endometriosis diagnosis: A qualitative study on medical stigma and healthcare-seeking behavior with endometriosis in a German sample 2026
- A transcriptomics-based computational drug repurposing pipeline identifies simvastatin and primaquine as therapeutics for endometriosis 2026
- Cannabidiol-Enriched Extract Oil for Postoperative Management of Chronic Pelvic Pain Secondary to Endometriosis: A Randomized Clinical Trial-DREAMLAND Study 2026
- Extracellular matrix composition and stiffness regulates progesterone responsiveness and decidualization 2026
- [Pain medicine aspects of the updated S2k guideline "Diagnosis and treatment of endometriosis"] 2026
- A multicenter randomized placebo-controlled trial evaluating daidzein-rich isoflavone aglycones in endometriosis-associated dysmenorrhea 2026
- Online-CBT for endometriosis: Exploring the acceptability and impact of the Ed.iTh program 2026
- Yearning for movement. A qualitative interview study exploring physical activity in the context of endometriosis-associated chronic pain 2026
- Unresolved challenges in endometriosis: diagnostic delay, disease progression and recurrence 2026
- Preferential innervation of endometriosis by hyperexcitable Ret/GFRα1+ nociceptors associates with target GDNF and clinical pain 2026
- Effects of Physical Interventions on Pain, Anxiety, and Depression in Women with Endometriosis: A Meta-Analysis 2026
- Endometriosis-associated Pain: Mechanism, Neuroimmune Signature, and Translational Precision Strategies 2026
- Neuropelveology in Endometriosis: Pain Mechanisms, Diagnostic Implications, and Surgical Decision-Making 2026
- Persistent Pelvic Adhesions and Fibrotic Remodeling Following Ectopic Lesion Ablation in a Mouse Model of Endometriosis 2026
- Simvastatin and Primaquine Identified as Potential Endometriosis Therapeutics via a Novel Epithelial-Stromal Assembloid Drug Screening Assay 2026
- Depressive symptoms, mental disorders, and treatment-seeking behavior in endometriosis: A cross-sectional study of prevalence and associations with quality of life 2026
- Central Sensitization and Hormonal Therapy Failure for Endometriosis-Related Pain Symptoms: A Prospective Study 2026
- Guideline No. 468: Clinical Management of Endometriosis 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Stilbene-based strategies for the management of endometriosis: targeting cell adhesion, migration, and ECM-driven invasion 2026
- Effects of Physical Interventions on Pain, Anxiety, and Depression in Women with Endometriosis: A Meta-Analysis 2026
- The mental health burden of endometriosis: a narrative review 2026
- PREDICTORS OF DRUG RESISTANCE DEVELOPMENT IN HORMONE THERAPY FOR ENDOMETRIOSIS 2026
- THE IMPACT OF SELECTED DIETS AND NUTRIENTS ON THE DEVELOPMENT AND PROGRESSION OF ENDOMETRIOSIS: A LITERATURE REVIEW 2026
- Endométriose ovarienne 2026
- Hormonal factors are poor indicators of endometriosis pain 2026
- Endometriosis and chronic pain syndrome: The role of stress mechanisms 2026
- Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate-to-Severe Endometriosis Pain: A Phase III, Multicentric, Double-Blind, Active-Controlled, Non-Inferiority Study 2026
- Rethinking first-line progestin use in endometriosis: a comparative therapeutic review and future-ready drug delivery perspective 2026
- Preliminary Materials for a Situated Knowledge of Endometriosis 2026
- Evaluating the impact of cannabinoid extracts on chronic pain and quality of life in endometriosis patients - a pilot study 2026
- ФАКТОРЫ РИСКА ПОВТОРНОГО РАЗВИТИЯ ЭНДОМЕТРИОИДНЫХ КИСТ ЯИЧНИКОВ И ВОЗМОЖНОСТИ ПРОФИЛАКТИКИ РЕЦИДИВОВ 2026
- Endometriosis: A Review 2025
- Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
- Spinal-Cord Stimulation for Intractable, Visceral Pain Associated With Endometriosis: Positive Results of a Feasibility Study 2025
- Targeting inflammation in endometriosis: emerging therapeutic options 2025
- Role of Salivary MicroRNA as a Marker of Progesterone Resistance in Endometriosis: Preliminary Results from a Single-Institution Experience 2025
- Optimizing Patient Experiences and Outcomes: Proposal to Develop an Endometriosis Care Quality Collaborative in the United States 2025
- The role of pharmacotherapy in the treatment of endometriosis: an update 2025
- Endometriosis: pathophysiology and the potential role of diet 2025
- Exploring positive and negative body image and health-related quality of life in women with endometriosis: a latent profile analysis 2025
- Advancements in Ultrasound Diagnosis of Superficial Endometriosis: Current Challenges and Emerging Techniques 2025
- Impact of Surgeon Characteristics on Endometriosis Surgery Outcomes 2025
- Deep dyspareunia and central sensitization in endometriosis: A prospective study with online daily pain diary 2025
- The role of self-management in endometriosis pain: insights from a cross-sectional survey in Germany, Austria, and Switzerland 2025
- Changes in fatigue, health-related fitness, sleep quality, mental health, gastrointestinal complaints and sexual function after a multimodal supervised therapeutic exercise program in women with endometriosis unresponsive to conventional therapy: a secondary analysis of a randomized controlled trial 2025
- The Impact of Endometriosis on Mental Health - A Literature Review of Depression and Anxiety Symptoms 2025
- Therapeutic Management Strategy of Endometriomas 2025
- Systems Pharmacology Model Predicts Zinc and Copper Can Be Repurposed as Endometriosis Therapies 2025
- Novel targets for endometriosis-associated pain 2025
Source provenance
- europepmc
- last seen: 2026-11-18T06:10:28.346261+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:20:11.545185+00:00